Loading...
22nd Century Group reported a 12% increase in revenue compared to the same quarter last year. The company also saw a 16% reduction in operating expenses compared to the same quarter last year.
Revenue increased 12% over last year.
Manufacturing facility has remained open and has been able to fulfill orders without any backlog.
Operating expenses decreased by 16% compared to the same quarter last year.
FDA announced a deadline for public comments on the Company’s Modified Risk Tobacco Product (“MRTP”) application.
Analyze how earnings announcements historically affect stock price performance